ZEVIPTO
LIVE

Serial Number

79386352

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Nov 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ZEVIPTO Trademark

Serial Number: 79386352 • Registration: 7691329

ZEVIPTO is a trademark filed by NOVARTIS AG on November 8, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 8, 2023

Registration Date

February 18, 2025

Published for Opposition

December 31, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the above with the exception of pharmaceuticals for the prevention and treatment of central nervous system diseases and disorders

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 19, 2025 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Sep 1, 2025 FICS
FINAL DISPOSITION PROCESSED
Sep 1, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 13, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 27, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 18, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 3, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2024 CRFA
ASSIGNED TO LIE
Nov 6, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 15, 2024 TROA
NOTICE OF REVIVAL - E-MAILED
Aug 15, 2024 NREV
PETITION TO REVIVE-GRANTED
Aug 15, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Aug 15, 2024 PROA
REFUSAL PROCESSED BY IB
Mar 5, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 13, 2024 RFCS
REFUSAL PROCESSED BY MPU
Feb 13, 2024 RFRR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 5, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 5, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 5, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 5, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 5, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 5, 2024 COAR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 25, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jan 24, 2024 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 23, 2024 MAFR
ASSIGNED TO EXAMINER
Jan 18, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 29, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 28, 2023 REPR